CPT code 93314 designates the interpretation and report component of a transesophageal echocardiography (TEE) exam, used to evaluate cardiac valve and chamber function and detect structural heart disease. Nationally, TEE interpretation is critical for diagnosis and management of valve disease, prosthetic valve assessment, endocarditis evaluation, and intraoperative monitoring, making accurate coding and reporting important for clinical documentation and aggregate service tracking. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for TEE interpretation, typical sites of service, commonly applied modifiers, and the payers covered. The publication also summarizes benchmark considerations and policy-relevant issues affecting coverage and claims processing for interpretation-only TEE services. This material is intended for billing professionals, health system administrators, and clinicians who need a practical reference to CPT code 93314, its clinical use, and the payer landscape that affects billing and reimbursement workflows. Data not available in the input is noted where applicable.